Linda Kammerer

Linda Kammerer has a wealth of experience in the pharmaceutical and medical device industries. Linda is currently working at AN2 Therapeutics as the Director of Clinical Operations. Prior to this role, they were a Project Management Consultant at the same company.

Before joining AN2 Therapeutics, Linda worked as the Owner of PharmaSure Consulting, where they demonstrated their leadership skills and expertise in Electronic Data Capture, Good Clinical Practice, and third-party vendor management. Linda'srole at PharmaSure Consulting spanned from January 2020 to December 2022.

Linda also gained experience at various other organizations, including Santen, where they served as a Senior Clinical Project Manager from November 2020 to March 2021. At Illumina, they held positions as an Associate Director and Senior Manager, Clinical Affairs, overseeing international and domestic clinical trials in reproductive health.

Linda previously owned and served as President of Pharma-Sure, an independent clinical research consulting company specializing in ophthalmology trials for conditions such as Age-Related Macular Degeneration, cataracts, and uveitis. Linda's experience also includes roles as a Senior Clinical Research Consultant at Verinata Health, Inc., Rock Creek Pharmaceuticals, INC Research, Lux Biosciences, Inc., and NeoVista, Inc.

Overall, Linda Kammerer's extensive work experience showcases their expertise in clinical operations, project management, and monitoring of phase 1 to IV clinical trials in the pharmaceutical and medical device sectors, particularly in ophthalmology and reproductive health.

Linda Kammerer attended Penn State University from 1973 to 1977, where they obtained a Bachelor of Arts degree in Business Administration.